UTX-TGR-205 (Unity NHL)

Trial description
A Phase 2b Randomized Study to Assess the Efficacy and Safety of the Combination of Ublituximab + TGR-1202 with or without Bendamustine and TGR-1202 alone in Patients with Previously Treated Non-Hodgkin’s Lymphoma.
Contact name
Dr Dan Hodson
Trial start date
Friday, December 29, 2017
Trial end date
Tuesday, December 29, 2020
Trial tumour type
Haematological
Show on Radiotherapy
No